Trial Profile
Safety and efficacy of rituximab in patients with Idiopathic Inflammatory Myopathies: Experience From a Centre in Italy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jun 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Myositis
- Focus Therapeutic Use
- 19 Jun 2015 New trial record